Merck KGaA: forms strategic alliance with genOway

(CercleFinance.com) - French biotech company genOway and the German chemicals and pharmaceuticals group Merck have announced reaching a strategic alliance in the field of CRISPR/Cas9 models for the rodent model market, including an exclusive global license and a research partnership.


They will collaborate in the development of new technologies and innovative solutions using CRISPR/Cas9, a so-called "molecular scissors" technique that enables DNA to be cut at a specific place in the genome, in any cell.

genOway will use patented Merck's patented CRISPR/Cas9 technology to generate and sell rodent models worldwide. The financial terms of the agreement were not specified.

Copyright (c) 2018 CercleFinance.com. All rights reserved.